title: Mycobacterium fortuitum endophthalmitis.
abstract: OBJECTIVE
  The authors report the first known case of mycobacterium fortuitum endophthalmitis.
  
  
  METHODS
  The authors use the documentation of clinical course.
  
  
  RESULTS
  A postoperative cataract patient received a diagnosis of mycobacterium fortuitum endophthalmitis 1 month after uncomplicated cataract surgery. The endophthalmitis responded to intraocular amikacin.
  
  
  CONCLUSIONS
  When mycobacteria are recovered from patients with endophthalmitis, amikacin should be included in the therapeutic regimen until speciation and in vitro susceptibility testing documents equally effective alternatives.
authors.affiliation: Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: S
authors.initials: S
authors.lastname: Mutyala
authors.forename: J P
authors.initials: JP
authors.lastname: Dieckert
authors.forename: C J
authors.initials: CJ
authors.lastname: Papasian
mesh_terms: D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D000583:Amikacin / Q000008:administration & dosage / Q000627:therapeutic use; D002387:Cataract Extraction; D009877:Endophthalmitis / Q000382:microbiology*; D005260:Female; D006801:Humans; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000209:etiology; D011183:Postoperative Complications
chemical_list: D000583:Amikacin